Related references
Note: Only part of the references are listed.Paclitaxel poliglumex (PPX-xyotax) and concurrent radiation for esophageal and gastric cancer - A phase I study
Tom Dipetrillo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)
Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: Implications for radiotherapy of hepatocellular carcinoma
YL Chung et al.
CLINICAL CANCER RESEARCH (2006)
Paclitaxel poliglumex (XYOTAX™, CT-2103):: A macromolecular taxane
JW Singer
JOURNAL OF CONTROLLED RELEASE (2005)
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister et al.
LANCET ONCOLOGY (2005)
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer
DH Ilson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways
JS Park et al.
ONCOGENE (2001)
Share Paper
